641
Participants
Start Date
October 31, 2012
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Ceftazidime - Avibactam ( CAZ-AVI)
Ceftazidime 2000 mg and 500 mg of avibactam. Patients randomized to receive CAZ-AVI will receive an infusion of CAZ-AVI (2000 mg ceftazidime and 500 mg avibactam) every 8 hours administered by intravenous (IV) infusion in a volume of 100 mL at a constant rate over 120 minutes
Doripenem
500 mg of Doripenem. Patients randomized to receive Doripenem will receive an infusion of Doripenem 500 mg every 8 hours administered by intravenous (IV) infusion in a volume of 100 mL at a constant rate over 60 minutes
Either switch to oral therapy: 500 mg of Ciprofloxacin (oral)
Patients are eligible for oral switch after receiving 5 full days of IV therapy and have met protocol specified criteria for clinical improvement
or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Patients are eligible for oral switch after receiving 5 full days of IV therapy and have met protocol specified criteria for clinical improvement
Research Site, Detroit
Research Site, St Louis
Research Site, Indiana
Research Site, Rosario
Research Site, Pazardzhik
Research Site, Sofia
Research Site, Veliko Tarnovo
Research Site, Slavonski Brod
Research Site, Zadar
Research Site, Zagreb
Research Site, Liberec
Research Site, Prague
Research Site, Hamburg
Research Site, Haifa
Research Site, Kfar Saba
Research Site, Modena
Research Site, Cuernavaca, MOR
Research Site, Guadalajara
Research Site, Zapopan
Research Site, Arequipa
Research Site, Cercardo de Lima
Research Site, Cusco
Research Site, Lima
Research Site, Trujillo
Research Site, Bialystok
Research Site, Sochaczew
Research Site, Wroclaw
Research Site, Bucharest
Research Site, Oradea
Research Site, Sibiu
Research Site, Timișoara
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Novosibirsk
Research Site, Saint Petersburg
Research Site, Smolensk
Research Site, Tomsk
Research Site, Veliky Novgorod
Research Site, Busan
Research Site, Jeonnam
Research Site, Seoul
Research Site, Alicante
Research Site, Alzira (Valencia)
Research Site, Barcelona
Research Site, Elche
Research Site, Granada
Research Site, Terrassa
Research Site, Kaohsiung City
Research Site, Taipei
Research Site, Chernivtsi
Research Site, Ivano-Frankivsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Lutsk
Research Site, Simferopol
Research Site, Vinnytsia
Research Site, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Forest Laboratories
INDUSTRY
Pfizer
INDUSTRY